Emerging Trends Influencing The Growth Of The Genome Editing/Genome Engineering Market:Advancing Gene Editing Technologies In The Genome Engineering Frontier

The Genome Editing/Genome Engineering Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Genome Editing/Genome Engineering Market Size Expected to Be by 2034?
The size of the genome editing/genome engineering market has expanded swiftly in the past few years. Forecasts suggest the growth from $8.62 billion in 2024 to $10.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of 18.2%. The surge during the historical phase can be traced back to factors such as enhanced research in genomics and genetics, upswing in genetic disorders, progress in gene therapy, influx of investments in life sciences and biotechnology, possibilities in agricultural uses, and applications for model organisms.

The market size of genome editing/genome engineering is poised for rapid expansion in the upcoming years. Projected to reach $20.81 billion in 2029, it exhibits a compound annual growth rate (CAGR) of 19.5%. This growth within the prediction period can be credited to the advent of prime editing, emphasis on ethical and regulatory scaffolding, increased usage in drug discovery, therapeutic potential for genetic conditions, tailoring for gene function research, and a rising interest in epigenome editing. The forecast period is also highlighted by trends such as advancements in Crispr technology, expanding therapeutic applications, the introduction of fresh genome editing tools, investments and collaborations, improved delivery systems, and the incorporation of artificial intelligence (AI) in genome editing design.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8010

What Are the Emerging Segments Within the Genome Editing/Genome Engineering Market?
The genome editing/genome engineering market covered in this report is segmented -

1) By Product And Service: Reagents And Consumables, Software And systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

What Long-Term Drivers Are Shaping Genome Editing/Genome Engineering Market Trends?
The increase in cancer and other genetic diseases is predicted to boost the expansion of the genome editing/genome engineering market. Cancer is a disease where some cells in the body uncontrollably multiply and spread to other areas. Genome engineering has the ability to rapidly design immune cells and oncolytic viruses for anticancer therapies. For example, in February 2022, the World Health Organization (WHO), a health agency of the United Nations based in Switzerland, released an article revealing that nearly 10 million deaths, or nearly one out of every six, were attributed to cancer, making it the number one cause of mortality worldwide. Moreover, in June 2022, the U.S. Centers for Disease Control and Prevention (CDC), a nationwide public health organization, reported 1,752,735 new instances of invasive cancer in the U.S. in 2019, including 863,830 women and 888,905 men. The cancer incidence rate among the overall population was 439 per 100,000 individuals. Hence, the growing prevalence of cancer and other genetic abnormalities is stimulating the genome editing and genome engineering market's expansion.

Who Are the Top Competitors in Key Genome Editing/Genome Engineering Market Segments?
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

What Genome Editing/Genome Engineering Market Trends Are Gaining Traction Across Different Segments?
Key developments in gene editing technology are becoming a prominent trend in the genome editing/genome engineering market. Major players in this market are focused on developing innovative technological solutions to enhance their standing. For example, in May 2022, scientists from Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a research university from Spain specializing in evolutionary biology, introduced a fast and efficient approach to gene editing in insects. The new method, termed Direct parental CRISPR (DIPA-CRISPR), entails the injection of substances into developing eggs of adult females instead of embryos. This innovative approach allows researchers to bypass the process of microinjecting CRISPR material into insect embryos.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Which Regions Are Becoming Hubs for Genome Editing/Genome Engineering Market Innovation?
North America was the largest region in the gene editing/genome engineering market in 2024. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Genome Editing/Genome Engineering Market?
2. What is the CAGR expected in the Genome Editing/Genome Engineering Market?
3. What Are the Key Innovations Transforming the Genome Editing/Genome Engineering Industry?
4. Which Region Is Leading the Genome Editing/Genome Engineering Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.